Listen to CMHC's Senior Planning Committee Member, Dr. Keith C. Ferdinand, Professor of Medicine at the Tulane University School of Medicine in New Orleans, LA, discuss whether ACEis and ARBs should be withdrawn in patients with COVID-19.
Keith C Ferdinand, MD, is Professor of Medicine at the Tulane University School of Medicine and the Tulane Heart and Vascular Institute in New Orleans, Louisiana. He was previously Professor of Clinical Pharmacology at Xavier University, New Orleans and Clinical Professor of Medicine at Emory University, Atlanta, Georgia. Dr. Ferdinand received his medical degree from the Howard University College of Medicine in Washington, DC. He is board-certified in internal medicine and cardiovascular disease, certified in the subspecialty of nuclear cardiology, and a specialist in clinical hypertension certified by the American Society of Hypertension.
Dr. Ferdinand is past Chair of the National Forum for Heart Disease and Stroke Prevention and has served as Chief Science Officer and past chair of the Association of Black Cardiologists.Read More
In this podcast, Dr. Clyde Yancy, Professor of Medicine at Northwestern, discusses the connections between CVD and COVID-19, including cardiac injury, RAASi therapy, and more.
Follow Us Online